Analyst Ratings for NovaBay Pharmaceuticals (nby)
nby Rating Summary
nby Price Target Summary
- Highest: $3.50 (Roth Capital)
- Lowest: $2.25 (Ascendiant Capital)
- Average: $2.88
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.88 (+114.6%)
Avg. $ Target:
$2.88 (+114.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2013 | Ascendiant Capital | New Coverage | Strong Buy (N/A) |
2.25 (N/A) |
1.15 | 1.34 | 16.52% | Details |
| 4/12/2012 | Roth Capital | New Coverage | Buy (N/A) |
3.50 (N/A) |
1.28 | 1.34 | 4.69% | Details |
